AAKINBEV Trademark

Trademark Overview


On Tuesday, May 3, 2022, a trademark application was filed for AAKINBEV with the United States Patent and Trademark Office. The USPTO has given the AAKINBEV trademark a serial number of 79343924. The federal status of this trademark filing is REGISTERED as of Tuesday, February 21, 2023. This trademark is owned by Novartis AG. The AAKINBEV trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
aakinbev

General Information


Serial Number79343924
Word MarkAAKINBEV
Filing DateTuesday, May 3, 2022
Status700 - REGISTERED
Status DateTuesday, February 21, 2023
Registration Number6982649
Registration DateTuesday, February 21, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 6, 2022

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; all for the foregoing goods being for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 7, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSandoz AG
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Friday, January 19, 2024CHANGE OF OWNER RECEIVED FROM IB
Monday, June 12, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, May 24, 2023FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, May 24, 2023FINAL DISPOSITION PROCESSED
Sunday, May 21, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 21, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 21, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, December 13, 2022NOTIFICATION PROCESSED BY IB
Tuesday, December 6, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 6, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 23, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 23, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 8, 2022REFUSAL PROCESSED BY IB
Tuesday, November 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 31, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, October 30, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, October 30, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 28, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 28, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, October 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 28, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 20, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, October 20, 2022REFUSAL PROCESSED BY MPU
Saturday, August 27, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, August 26, 2022NON-FINAL ACTION WRITTEN
Wednesday, August 24, 2022ASSIGNED TO EXAMINER
Tuesday, July 12, 2022APPLICATION FILING RECEIPT MAILED
Thursday, July 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 6, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, June 30, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB